Development and preclinical assessment of a first-in-class small molecule inhibitor of FLIP

被引：0
作者：
Majkut, Joanna
Higgins, Catherine
Fox, Jennifer
Fiedler, Greti E.
Harrison, Timothy
Longley, Daniel B.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
基金：
英国惠康基金;
关键词：
D O I：
10.1158/1538-7445.AM2017-LB-305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-305
引用
收藏
页数：2
相关论文
共 50 条
[21]   First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators [J].
Abdel-Rahman, Somaya A. ;
Swiderek, Katarzyna ;
Gabr, Moustafa T. .
RSC MEDICINAL CHEMISTRY, 2023, 14 (09) :1767-1777
[22]   Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma [J].
C. Festuccia ;
A. Mancini ;
A. Colapietro ;
G. L. Gravina ;
F. Vitale ;
F. Marampon ;
S. Delle Monache ;
S. Pompili ;
L. Cristiano ;
A. Vetuschi ;
V. Tombolini ;
Y. Chen ;
T. Mehrling .
Journal of Hematology & Oncology, 11
[23]   First-in-class Small-molecule Inhibitor of Nox4 Promotes Reversal of Established Pulmonary Fibrosis [J].
Hecker, L. ;
Kato, K. ;
Papageorgiou, J. ;
Gokhale, V. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
[24]   An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer [J].
Ushijima, Miho ;
Shiota, Masaki ;
Matsumoto, Takashi ;
Kashiwagi, Eiji ;
Inokuchi, Junichi ;
Eto, Masatoshi .
CANCER SCIENCE, 2022, 113 (05) :1731-1738
[25]   Feasibility and safety of targeting mitochondria for cancer therapy - preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor [J].
Hayat, Umar ;
Elliott, Gary T. ;
Olszanski, Anthony J. ;
Altieri, Dario C. .
CANCER BIOLOGY & THERAPY, 2022, 23 (01) :117-126
[26]   AN ORAL FIRST-IN-CLASS SMALL MOLECULE RSK INHIBITOR SUPPRESSES AR VARIANTS AND TUMOR GROWTH IN PROSTATE CANCER [J].
Shiota, Masaki ;
Ushijima, Miho ;
Matsumoto, Takashi ;
Kashiwagi, Eiji ;
Inokuchi, Junichi ;
Eto, Masatoshi .
JOURNAL OF UROLOGY, 2022, 207 (05) :E98-E99
[27]   First-in-class: RGS protein inhibitor [J].
Kimple, A. J. ;
Siderovski, D. P. .
MOLECULAR INTERVENTIONS, 2007, 7 (01) :9-9
[28]   Preclinical development of a selective, potent small molecule ALK inhibitor [J].
Lovly, Christine M. ;
de Stanchina, Elisa ;
Liang, Chris ;
Pao, William .
CANCER RESEARCH, 2010, 70
[29]   The discovery and preclinical characterization of AMG 176: A first-in-class Mcl-1 inhibitor in clinical development for multiple myeloma [J].
Hughes, Paul E. .
CANCER RESEARCH, 2017, 77
[30]   Preclinical Pharmacokinetics and Pharmacodynamics of Pinometostat (EPZ-5676), a First-in-Class, Small Molecule S-Adenosyl Methionine Competitive Inhibitor of DOT1L [J].
Waters, Nigel J. .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2017, 42 (06) :891-901
12345